BIIB

HOLD

Biogen Inc.

Healthcare · Rank #6 · Analyzed Oct 18, 2026

$232.65

Current Price

$536.54

Intrinsic Value

+130.6%

Upside/Downside

8.9/10

Score

2.5/5

Quality

Analysis Summary

Valuation Consensus2/3 methods agree

Quality Score2.5/5.0

Framework RatingHOLD

Price vs Intrinsic ValueUndervalued by 130.6%

Fair Value Range

Low$14.01

Base (IV)$536.54

High$679.35

Entry Points

Conservative$9.81

Moderate$14.01

Aggressive$375.57

Quality & Moat Breakdown

Return on Equity4.6% → 0/1.0

Debt LevelD/E 44 → 0.5/1.0

Revenue QualityGrowth 2.7%, margin Δ-3.5% +recovery → 1.0/1.0

Moat Strength3.0/5 → 0.5/1.0

Profit Margins8.3% → 0.5/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.